| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 903.84M | 819.79M | 857.39M | 714.42M | 740.29M |
| Gross Profit | 316.74M | 305.27M | 331.69M | 259.26M | 267.32M |
| EBITDA | 177.02M | 206.21M | 269.15M | 164.98M | 216.72M |
| Net Income | 68.66M | 22.06M | 137.20M | 48.49M | 74.52M |
Balance Sheet | |||||
| Total Assets | 3.24B | 2.84B | 3.10B | 2.84B | 3.06B |
| Cash, Cash Equivalents and Short-Term Investments | 842.80M | 331.52M | 484.56M | 305.71M | 317.88M |
| Total Debt | 283.59M | 246.11M | 275.02M | 258.04M | 344.16M |
| Total Liabilities | 998.52M | 837.17M | 1.03B | 945.66M | 1.20B |
| Stockholders Equity | 1.83B | 1.88B | 1.93B | 1.78B | 1.77B |
Cash Flow | |||||
| Free Cash Flow | 189.06M | -31.77M | 221.29M | 23.86M | 327.66M |
| Operating Cash Flow | 239.12M | -23.94M | 228.72M | 63.74M | 388.45M |
| Investing Cash Flow | 109.31M | -48.83M | -30.11M | -64.08M | -41.19M |
| Financing Cash Flow | -3.79M | -83.13M | -12.55M | -19.84M | -281.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$629.14M | 1.63 | 4.70% | 7.27% | 7.18% | -20.03% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | HK$85.31M | ― | 0.64% | ― | 17.22% | ― | |
53 Neutral | HK$1.52B | -1.51 | -33.88% | ― | -17.20% | 6.04% | |
52 Neutral | HK$426.61M | 5.63 | 3.70% | 9.12% | 13.15% | 197.79% | |
51 Neutral | HK$441.00M | 48.09 | -0.77% | 8.55% | -1.86% | -105.19% | |
42 Neutral | HK$128.64M | -2.39 | -31.93% | ― | 282.81% | 70.70% |